Hormone replacement therapy will no longer carry a warning label, FDA says​Hormone replacement therapy will no longer carry a warning label, FDA says 

 Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, FDA officials announced.  ​​Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, FDA officials announced.